Search
for
Sort by
Research 211–240 of 230
- Bioactive Proteolytic Enzymes Chymotrypsin and Papain as Adjuvants to Laser Hair Removal: Reducing the Risk of Paradoxical Hypertrichosis in Women with Facial Hirsutism
- Polycystic ovary syndrome: pragmatic management across levels of care
- Effects of Gymnema sylvestre Leaf Extract Formulation on Hair Growth Inhibition in C3H mice
- Characterization and Management of Adverse Events of Low-Dose Oral Minoxidil Treatment for Alopecia: A Narrative Review
- Dermatological care of gender‐diverse patients in Australia
- Dermatological considerations for transgender and gender diverse patients: An Australian perspective
- A comparative study of different treatment modalities of polycystic ovarian syndrome in women of reproductive age group at tertiary care centre
- Role of Drug Repurposing in Sustainable Drug Discovery
- Low-Dose Oral Minoxidil for Alopecia: A Comprehensive Review
- The Transgender: Endocrinological Assessment
- Polycystic ovary syndrome: Diagnosis and management
- 34979 Medical therapies and commercial products used by transgender men to enhance facial and body hair
- Congenital Adrenal Hyperplasia
- Recent Approaches in the Treatment of Polycystic Ovary Syndrome: An Update
- Hair and diabetes
- Androgenisierung: Diagnostik und Therapie – Akne vulgaris, Hirsutismus, female pattern hair loss
- Enzymes
- Polycystic Ovary Syndrome and the Metabolic Syndrome Long-Term Risks
- ZALCITABINE
- Die Menopause und ihre Auswirkungen auf Haut und Haare
- Randomized, double‐blind clinical evaluation of the efficacy and safety of topical eflornithine HCl 13.9% cream in the treatment of women with facial hair
- A randomized bilateral vehicle-controlled study of eflornithine cream combined with laser treatment versus laser treatment alone for facial hirsutism in women
- Topical Eflornithine
- Vaniqa--eflornithine 13.9% cream.
- Topical eflornithine hydrochloride improves the effectiveness of standard laser hair removal for treating pseudofolliculitis barbae: A randomized, double-blinded, placebo-controlled trial
- A method to improve the efficacy of topical eflornithine hydrochloride cream
- Adjuvant eflornithine to maintain IPL‐induced hair reduction in women with facial hirsutism: a randomized controlled trial
- Human Dermal Safety Studies with Eflornithine HCl 13.9% Cream (Vaniqa™), a Novel Treatment for Excessive Facial Hair
- Repurposing With Purpose: Treatment of Bachmann–Bupp Syndrome With Eflornithine and Implications for Other Polyaminopathies
- Synergy of Eflornithine Cream with Laser and Light-Based Systems for Hair Management